A Study of Guselkumab for the Treatment of Palmoplantar-non-Pustular Psoriasis

NCT03998683 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

117

Enrollment

INDUSTRY

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Guselkumab 100 mg
DRUG: Placebo

Sponsor

Janssen-Cilag Ltd.